The Board of Overseers is an advisory body committed to providing counsel and support to the ADDF Board of Governors and staff. Overseers lend their expertise to advance the ADDF's mission to accelerate the discovery of drugs to prevent, treat and cure Alzheimer’s disease. Overseers are appointed by and serve at the pleasure of the Board of Governors.


Sharon T. Sager, CIMA

Managing Director and Private Wealth Advisor, UBS Private Wealth Management

Carol Seabrook Boulanger

Partner, Pillsbury, Winthrop, Shaw, and Pittman, LLP

Charles Cangro

Principal, Personal Financial Services, Ernst & Young, LLC (Retired)

Mitchell D. Eichen, J.D., LL.M.

Founder and Chief Executive Officer, Acertus Capital Management
Founder and Chief Executive Officer, The MDE Group

Stephanie Ginsberg

Volunteer, Philanthropist; Founder, BCRF Pink Promises Benefit

Allan M. Green, MD, PhD, JD

Allan M. Green Esq., LLC

Christopher Johnson

President, Rackson Companies

Mitchell Kaneff

Chairman and CEO, Arkay Packaging

Bonnie Englebardt Lautenberg

Photographer and Writer, Bonnie Lautenberg Designs

Elise Gelman Lefkowitz


Philip Lovett

Founding Partner, Millennium Partners

Julie Medler

Managing Director, Golden Seeds

Justin Meltzer

Real Estate Operations, DLA Piper LLP

Pamela J. Newman, Ph.D.

President and Chief Executive Officer, PJN Strategies

Phebe Farrow Port

Senior Vice President, Global Management Strategies and Chief of Staff, Executive Management Initiatives, The Estée Lauder Companies Inc.

Gregory A. Rosica

Partner, Tax, Ernst & Young, LLC

Tom Scanlan

Consultant, Spencer Stuart

John H. Scully, CIMA

Senior Managing Director, Head of Private Wealth Advisory, Nuveen Investments

Stephen Toma

Managing Director, VJMS, LLC

Wendy L. Wilshin

Founder and Principal, WLW Designs